Alterations of biliary lipid composition in patients with fatty liver and those with cholesterol gallstone disease
Alterations of biliary lipid composition in patients with fatty liver and those with cholesterol gallstone disease
批准号:
06670519
负责人:
SHODA Junichi
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
胆固醇过饱和胆汁的形成是胆固醇结石疾病的先决条件。为了阐明胆固醇结石患者胆固醇过饱和胆汁形成的机制,除了肝脏的胆固醇生成和胆汁酸的合成外,我们还重点研究了胆囊壁和小肠的运动,这两种运动在维持胆汁酸的肠-肝循环中起重要作用。与正常对照组相比,胆石症患者胆汁酸的小肠转运和吸收无明显延长和损害。因此,患者可能不会表现出胆汁酸循环池减少的特征,因此他们的胆汁不会因胆固醇而变得过饱和。然而,在胆囊排空障碍的患者中,胆汁酸的小肠转运和吸收明显延长和受损。在这种情况下,胆汁过饱和可能是由于胆汁酸分布的变化导致循环胆汁酸池减少所致,例如,胆汁酸滞留到低动力胆囊部和肠部。与对照组相比,胆石症患者肝脏新生胆固醇合成显著减少。进一步认为,在胆固醇过饱和胆汁的形成过程中,外源性胆固醇的高分泌可能起着重要作用。
英文摘要
Formation of cholesterol supersaturated bile is a prerequisite for cholesterol gallstone disease. In order to elucidate mechanisms responsible for cholesterol supersaturated bile formation in patients with cholesterol gallstone disease, we focused on the motility of the gallbladder and small intestine, both of which are important in maintaining enterohepatic circulation of bile acids, in addition to the hepatic cholesterogenesis and bile acid synthesis. In gallstone patients with intact gallbladder emptying, the small intestinal transit and absorption of bile acids were not prolonged and impaired, as compared with control subjects. Therfore, the patients may not exhibit the characteristics of a decrease in circulating pool of bile acids, and accordingly their gallbladder bile does not become supersaturated with cholesterol. However, in patients with impaired gallbladder emptying, the small intestinal transit and absorption of bile acids were significantly prolonged and impaired. In such cases, the supersaturation of gallbladder bile may be due to the reduced pool of circulating bile acids brought about by changes in bile acid distribution, e.g., a sequestration into the hypomotile gallbladder and intestine. In gallstone patients, hepatic de novo cholesterol synthesis was significantly decreased as compared with control subjects. it is further suggested that in the formation of cholesterol supersaturated bile a hypersecretion of cholesterol derived from an exogeneous source may play a significant role.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Honda A, et al.: "Accumulation of 7α-hydroxycholesterol in liver tissue from cholesterol gallstone patients." Journal of Gastroenterology. (in press).
Honda A 等人:“胆固醇胆结石患者肝组织中 7α-羟基胆固醇的积累。”胃肠病学杂志(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Honda A, et al.: "Accumlation of 72-hydroxycholesterol in liver tissue from cholesterol gallstone patcents" Journal of Gastroenterology. 30. 651-656 (1995)
Honda A 等人:“胆固醇胆结石患者肝组织中 72-羟基胆固醇的累积”胃肠病学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshida T, et al.: "Determination of 7α-hydroxy-4-cholesten-3-one level in human plasma using isotopedilution mass spectrometry and monitoring its circadian rhythm in human as an index" Journal of Chromatography Biomedical Application. 655. 179-187 (1994)
Yoshida T 等人:“使用同位素稀释质谱法测定人血浆中的 7α-羟基-4-胆固醇-3-酮水平并监测其昼夜节律作为指标”《色谱生物医学应用杂志》655。179-。 187 (1994)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shoda J,He B,Tanaka N,Matsuzaki Y.Osuga T,Yamamori S,Miyazaki H,Sjovall J: "Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone diseases and its correlation with de novo syntheses of cholesterol and bile acids in liver,
Shoda J,He B,Tanaka N,Matsuzaki Y.Osuga T,Yamamori S,Miyazaki H,Sjovall J:“胆固醇胆结石疾病患者过饱和胆汁中脱氧胆酸的增加及其与胆固醇和胆汁酸从头合成的相关性
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shoda J, et al.: "Plasma levels of mevalonate and 7d-hydroxy-4-cholesten-3-one in cholesterol gallstone disease and their etiological significance" Journal of Gastroenterology. 29. 94- (1994)
Shoda J 等人:“胆固醇胆结石疾病中甲羟戊酸和 7d-羟基-4-胆甾烯-3-酮的血浆水平及其病因学意义”《胃肠病学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 16 条
Improvement of metabolic and exercise function of skeletal muscles through activation of transcription factor, and prevention of obesity-related liver disease
-
批准号:23300250
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.48万
-
财政年份:2011
-
负责人:SHODA Junichi
-
依托单位:
Inhibitory effects of exercise on progression of obesity-related liver diseases and development of glyco-biomarkers to scale the pathophysiology of the liver diseases
-
批准号:22650162
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.07万
-
财政年份:2010
-
负责人:SHODA Junichi
-
依托单位:
Development of novel cytotoxin therapy that targets tumor-associated surface molecules of biliary tract carcinoma
-
批准号:20390339
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.48万
-
财政年份:2008
-
负责人:SHODA Junichi
-
依托单位:
Analysis of mucin glycoproteins in the gallbladder of BK5.erbB2 transgenic mouse
-
批准号:15590618
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:SHODA Junichi
-
依托单位:
Inflammation-Associated Lipid Mediators in Cholestatic Hepatobiliary Diseases and Effect of PAF-AH
-
批准号:12670456
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2000
-
负责人:SHODA Junichi
-
依托单位:
Pathogenetic Mechanism for Hypersecretion of Mucin Glycoprotein in Cholelithiasis
-
批准号:09670509
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1997
-
负责人:SHODA Junichi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
海马神经元胆固醇代谢重编程致染色质组蛋白乙酰化水平降低介导老年小鼠术后认知功能障碍
-
批准号:82371192
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田婕
-
依托单位:
PDLIM3-Cholesterol-SMO轴调控SHH通路激活及其在髓母细胞瘤中的功能研究
-
批准号:82072798
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:张丽
-
依托单位:
以促内涵体逃逸聚合物PEG-P[Asp(TEP)]-cholesterol为载体构建双级脑靶向基因传递系统沉默BACE1基因的研究
-
批准号:81302714
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:俞媛
-
依托单位: